BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace


nference logo



AI Companies (Drug Discovery)

Powered by its artificial intelligence software platform, nferX, nference's mission is to synthesize the exponentially growing biomedical knowledge. nferX uses state-of-the-art neural networks (shallow and deep learning models) for real-time, automated extraction of knowledge from the commercial, scientific and regulatory body of literature. The platform enables a diverse set of applications ranging from R&D to commercial strategy and operations in the life sciences ecosystem. The long-term goal of the nferX platform is to become the connecting fabric of the various silos of information that exist across health care. Founded by Murali Aravamudan and Venky Soundararajan, Ph.D., nference is led by a multidisciplinary team of serial entrepreneurs from the tech and biotech worlds and PhDs in Biology/Genomics from MIT and Harvard Medical School. The investors in nference are Matrix Partners and Matrix Capital Management.

Become a Member to view additional information about this company